Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-01 Option Award |
2024-11-05 5:12 pm |
N/A 2034-11-01 |
Actinium Pharmaceuticals Inc. | ATNM | Almenoff June Sherie Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-12-28 Option Award |
2023-12-29 5:24 pm |
N/A 2033-12-28 |
Actinium Pharmaceuticals Inc. | ATNM | Nicholson C. David Director |
70,311 | $0 | 70,311 (Direct) |
View |
| 2023-12-28 Option Award |
2023-12-29 5:23 pm |
N/A 2033-12-28 |
Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director |
70,311 | $0 | 70,311 (Direct) |
View |
| 2023-12-28 Option Award |
2023-12-29 5:20 pm |
N/A 2033-12-28 |
Actinium Pharmaceuticals Inc. | ATNM | O'Loughlin Steve Chief Financial Officer |
253,123 | $0 | 253,123 (Direct) |
View |
| 2023-12-28 Option Award |
2023-12-29 5:18 pm |
N/A 2033-12-28 |
Actinium Pharmaceuticals Inc. | ATNM | Shetty Ajit Director |
70,311 | $0 | 70,311 (Direct) |
View |
| 2023-12-28 Option Award |
2023-12-29 5:17 pm |
N/A 2033-12-28 |
Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH Chief Executive Officer |
984,367 | $0 | 984,367 (Direct) |
View |
| 2023-12-28 Option Award |
2023-12-29 5:15 pm |
N/A 2033-12-28 |
Actinium Pharmaceuticals Inc. | ATNM | Chell Jeffrey W. Director |
70,311 | $0 | 70,311 (Direct) |
View |
| 2022-08-17 Option Award |
2022-08-19 4:55 pm |
N/A N/A |
Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH Chief Executive Officer |
300,000 | $0 | 305,381 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-01 7:19 pm |
N/A 2032-07-01 |
Actinium Pharmaceuticals Inc. | ATNM | O'Loughlin Steve Chief Financial Officer |
256,438 | $0 | 256,348 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-01 7:17 pm |
N/A 2032-07-01 |
Actinium Pharmaceuticals Inc. | ATNM | Nicholson C. David Director |
72,156 | $0 | 72,156 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-01 7:16 pm |
N/A 2032-07-01 |
Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director |
72,156 | $0 | 72,156 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-01 7:14 pm |
N/A 2032-07-01 |
Actinium Pharmaceuticals Inc. | ATNM | Shetty Ajit Director |
72,156 | $0 | 72,156 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-01 7:13 pm |
N/A 2032-07-01 |
Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH Chief Executive Officer |
827,366 | $0 | 827,366 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-01 7:11 pm |
N/A 2032-07-01 |
Actinium Pharmaceuticals Inc. | ATNM | Chell Jeffrey W. Director |
72,156 | $0 | 72,156 (Direct) |
View |
| 2021-09-01 Option Award |
2021-09-03 5:05 pm |
N/A 2031-09-01 |
Actinium Pharmaceuticals Inc. | ATNM | Chell Jeffrey W. Director |
18,351 | $0 | 18,351 (Direct) |
View |
| 2021-09-01 Option Award |
2021-09-03 5:04 pm |
N/A 2031-09-01 |
Actinium Pharmaceuticals Inc. | ATNM | Berger Mark Stanley Chief Medical Officer |
67,164 | $0 | 67,164 (Direct) |
View |
| 2021-09-01 Option Award |
2021-09-03 5:03 pm |
N/A 2031-09-01 |
Actinium Pharmaceuticals Inc. | ATNM | Shetty Ajit Director |
18,351 | $0 | 18,351 (Direct) |
View |
| 2021-09-01 Option Award |
2021-09-03 5:02 pm |
N/A 2031-09-01 |
Actinium Pharmaceuticals Inc. | ATNM | O'Loughlin Steve Chief Financial Officer |
107,463 | $0 | 107,463 (Direct) |
View |
| 2021-09-01 Option Award |
2021-09-03 5:02 pm |
N/A 2031-09-01 |
Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director |
18,351 | $0 | 18,351 (Direct) |
View |
| 2021-09-01 Option Award |
2021-09-03 5:01 pm |
N/A 2031-09-01 |
Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH Chief Executive Officer |
310,182 | $0 | 310,182 (Direct) |
View |
| 2021-09-01 Option Award |
2021-09-03 5:00 pm |
N/A 2031-09-01 |
Actinium Pharmaceuticals Inc. | ATNM | Nicholson C. David Director |
18,351 | $0 | 18,351 (Direct) |
View |
| 2020-08-12 Option Award |
2020-08-14 5:21 pm |
N/A 2030-08-12 |
Actinium Pharmaceuticals Inc. | ATNM | O'Loughlin Steve Chief Financial Officer |
59,066 | $0 | 59,066 (Direct) |
View |
| 2020-08-12 Option Award |
2020-08-14 5:21 pm |
N/A 2030-08-12 |
Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH Chief Executive Officer |
139,062 | $0 | 139,062 (Direct) |
View |
| 2020-08-12 Option Award |
2020-08-14 5:18 pm |
N/A 2030-08-12 |
Actinium Pharmaceuticals Inc. | ATNM | Chell Jeffrey W. Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2020-08-12 Option Award |
2020-08-14 5:17 pm |
N/A 2030-08-12 |
Actinium Pharmaceuticals Inc. | ATNM | Berger Mark Stanley Chief Medical Officer |
46,667 | $0 | 46,667 (Direct) |
View |
| 2020-08-12 Option Award |
2020-08-14 5:03 pm |
N/A 2030-08-12 |
Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2020-08-12 Option Award |
2020-08-14 5:03 pm |
N/A 2030-08-12 |
Actinium Pharmaceuticals Inc. | ATNM | Shetty Ajit Director |
8,333 | $0 | 8,333 (Direct) |
View |
| 2020-08-12 Option Award |
2020-08-14 5:03 pm |
N/A 2030-08-12 |
Actinium Pharmaceuticals Inc. | ATNM | Ludwig Dale L. Chief Science & Tech. Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-08-12 Option Award |
2020-08-14 5:02 pm |
N/A 2030-08-12 |
Actinium Pharmaceuticals Inc. | ATNM | Nicholson C. David Director |
8,333 | $0 | 8,333 (Direct) |
View |